COCP - Cocrystal Year-over-year net earnings per share growth for the last 12 months

COCP (Cocrystal Pharma) - company brandmark

Cocrystal Pharma, Inc. (COCP) delegates drug production and testing to external contractors, as it does not own its own manufacturing plants. Experienced management focuses on patents and clinical development. GURU.Markets clearly illustrates comparable quarterly EPS growth, and the current parameter is -13.70. The company is currently undergoing early-stage trials, competing with other biotech startups to attract investment capital.

cocrystalpharma.com (COCP) Year-over-year net earnings per share change for the last twelve months: for the period 07/04/2022 - 11/15/2026

Analytical breakdowns for Cocrystal Pharma, Inc.

- market value and analyst target forecast:
Price Chart Cocrystal|COCP - Fair Value Consensus
- market capitalization statistics:
Market Valuation Cocrystal Pharma Corp|COCP - Enterprise Value
- book capitalization indicators:
Net Assets per Single Share Cocrystal Pharma|COCP - Book Valuation of Business|Market Capitalization to Book Value Ratio cocrystalpharma.com|COCP - Cumulative Company Assets
- debt and liquidity data:
Debt to Equity Cocrystal Pharma, Inc.|COCP - Long-Term Liabilities to Capital|Short-Term Debt to Capital Cocrystal Pharma Inc|COCP - Company Total Debt|Debt to Book Capitalization Ratio Cocrystal Pharma, Inc.|COCP - Company Long-Term Loans and Borrowings|Company Current Liabilities Cocrystal Pharma|Quick Liquidity cocrystalpharma.com
- earnings and market multiples details:
COCP - Net Financial Result|Future Profit Cocrystal Pharma, Inc.|COCP - Market Price to Net Income Ratio|Forward P/E Multiple Cocrystal Pharma Corp|COCP - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cocrystal Pharma|COCP - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Cocrystal Pharma|COCP - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months cocrystalpharma.com|COCP - Earnings per share trend in current year|Earnings growth forecast for next year Cocrystal Pharma, Inc.
- sales and revenue data:
COCP - Company Sales Revenue|Projected Sales Volume Cocrystal Pharma Inc|COCP - P/S Multiple|Price-to-Projected Revenue Ratio Cocrystal Pharma, Inc.
Basic company analysis:Cocrystal Pharma, Inc.
Manufactured product of Cocrystal Pharma Corp

This indicator measures the quarterly dynamics of earnings per share, reflecting the actual efficiency of capital generation and the pace of business scaling. By analyzing the quarter-over-quarter EPS growth rate, an investor can assess the financial stability of Cocrystal Pharma, Inc. (COCP), where an increase in this metric would confirm the monetization of innovations in the crystalline structure of drugs and the company's future pricing power in the pharmaceutical market.

Who Cocrystal Pharma, Inc. competes with

Gilead Sciences Inc (GILD) - Year-over-year earnings per share growth for the last twelve months|Cidara - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months NVAX|Quarterly EPS earnings growth curevac.com|Year-over-year earnings per share growth for the last twelve months Valneva Corp (VALN)|Year-over-year earnings per share growth for the last twelve months VIR (Vir Biotechnology)|Year-over-year earnings per share growth for the last twelve months TPOXX SIGA|EBS - Year-over-year net earnings per share growth for the last 12 months|AVIR: Year-over-year net earnings per share growth for the last 12 months|IVVD (Invivyd Inc) - Year-over-year earnings per share growth for the last 12 months|ENTA: Quarterly EPS earnings growth|INO (Inovio) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months HilleVax Corp|Quarterly EPS earnings growth Kalaris Tx|Quarterly EPS earnings growth DYAI|Year-over-year earnings per share growth for the last twelve months NNVC (NanoViricides)|Quarterly EPS earnings growth TLPH (Talphera Corporation)|Year-over-year earnings per one share growth for the last 12 months TRAW|Dogwood Therapeutics Inc. - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Qualigen Corp|ALVR (AlloVir Bio) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months VBI Vaccines, Inc.|VIRI (virios.com) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months VXRT (Vaxart, Inc.)